Abstract Background and Objective Trastuzumab deruxtecan (T-DXd) is a novel anti-ERBB2
antibody drug conjugate that appears to be associated with an increased risk of lung toxicity …

Background Approximately one‐third of individuals with interstitial lung disease (ILD) have
associated connective tissue disease (CTD). The connective tissue disorders most …

Extra-articular Manifestations in Rheumatoid Arthritis - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …

Background and objective Transbronchial lung biopsy (TBLB) is required for evaluation in
selected patients with interstitial lung disease (ILD). The diagnostic yield of histopathologic …

Purpose Anti-human epidermal growth factor receptor 2 (HER2) therapies are associated
with interstitial lung disease (ILD), also referred to as pneumonitis. In this literature review …

The opportunity of a multidisciplinary evaluation for the diagnosis of interstitial pneumonias
highlighted a major change in the diagnostic approach to diffuse lung disease. The new …

Acute respiratory distress syndrome (ARDS) is a devastating critical illness that can be
triggered by a wide range of insults and remains associated with a high mortality of around …

Rheumatoid arthritis (RA) is a systemic autoimmune disease affecting 0.5–1% of the
worldwide population. Whilst predominantly causing chronic pain and inflammation in …

Background Exercise training is important in the management of adults with chronic
pulmonary conditions. However, achieving high intensity exercise may be challenging for …

Rheumatoid arthritis (RA) is a systemic inflammatory disease which primarily causes
symmetric polyarthritis. An extrarticolar involvement is common and lungs are commonly …